Molecular Characterization of Non‐Specific Esophagitis Reveals a Distinct Non‐Eosinophilic Phenotype With Fibrotic Traits
BACKGROUND: Non-specific esophagitis has been recently described in patients with dysphagia not fulfilling criteria for eosinophilic esophagitis (EoE). Whether it is a distinct entity and how dysphagia can develop in the absence of eosinophilic infiltration remains unknown. OBJECTIVE: In this study, we comprehensively characterized non-specific esophagitis aiming to elucidate eosinophil-independent fibrosis mechanisms. METHODS: We cross-sectionally and longitudinally analyzed treatment-naïve patients presenting with non-specific esophagitis defined by esophageal dysfunction and low-grade lymphocytic infiltration (< 30 lymphocytes/hpf) in the absence of tissue eosinophilia and reflux disease (GERD). We compared clinical, endoscopic, (immuno)-histological disease activity to EoE, lymphocytic esophagitis, and GERD. RNA sequencing was performed to investigate disease mechanisms. RESULTS: We identified 19 patients (6 males, median age 48 years), with a follow-up of 20 months (IQR 10-41). Clinical disease burden was considerable, contrasting mild endoscopic activity (EREFS 0, IQR 0-2). Immunostaining of esophageal biopsies did not reveal increased numbers of eosinophils or mast cells as contributors to the disease. Lymphocytic infiltration (15/hpf, IQR 9-24) was not increased compared to healthy controls (9/hpf, IQR 9-10) or GERD patients (13/hpf, IQR 9-23); 14 (73.6%) patients were treated with topical steroids (symptomatic response in 85.7%) and 6 patients (31.6%) underwent endoscopic dilation. Progression to EoE was observed in 1 patient, while esophageal eosinophilia (< 15 eos/hpf) developed in 3 patients. RNA sequencing (n = 10) revealed a distinct transcriptomic profile, with highly enriched fibrosis-related pathways. Immunostaining for E-Cadherin/Vimentin as a marker for epithelial-mesenchymal transition (EMT, n = 10) confirmed increased EMT compared to controls. CONCLUSION: Non-specific esophagitis appears to be a distinct non-eosinophilic phenotype with fibrotic traits. Our data suggest eosinophil-independent development of fibrosis.
Authors
- Emilie Gueguen (ORCID: https://orcid.org/0000-0002-8187-8792)
- Ikuo Hirano (ORCID: https://orcid.org/0000-0001-7688-9377)
- Marcin Wawrzyniak (ORCID: https://orcid.org/0000-0002-6911-8010)
- D Simon
- Hans‐Uwe Simon (ORCID: https://orcid.org/0000-0002-9404-7736)
- Fouad J. Moawad (ORCID: https://orcid.org/0000-0002-4530-1523)
- Glenn T. Furuta (ORCID: https://orcid.org/0000-0003-3262-3571)
- Darko Stojkov (ORCID: https://orcid.org/0000-0001-9243-3759)
- Marc Pfefferlé (ORCID: https://orcid.org/0000-0001-6196-2367)
- L Biedermann
- M Chehade
- Thomas Greuter
- Margaret H Collins
- Alain M Schoepfer
- Alex Straumann
- Evan S Dellon
- Nirmala Gonsalves
Institutions
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Bern (CH)
- Cincinnati Children's Hospital Medical Center (US)
- University Hospital of Bern (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- Ospedale regionale di Lugano (CH)
- Children's Hospital Colorado (US)
- University Hospital of Zurich (CH)
- Spital Limmattal (CH)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Scripps Clinic (US)
- Università della Svizzera italiana (CH)
- University of Colorado Denver (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Allergy
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1111/all.70364
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung